Your browser doesn't support javascript.
loading
Suboptimal Concentrations of Ceftazidime/Avibactam (CAZ-AVI) May Select for CAZ-AVI Resistance in Extensively Drug-Resistant Pseudomonas aeruginosa: In Vivo and In Vitro Evidence.
Lopez-Montesinos, Inmaculada; Montero, María Milagro; Domene-Ochoa, Sandra; López-Causapé, Carla; Echeverria, Daniel; Sorlí, Luisa; Campillo, Nuria; Luque, Sonia; Padilla, Eduardo; Prim, Nuria; Grau, Santiago; Oliver, Antonio; Horcajada, Juan P.
Afiliação
  • Lopez-Montesinos I; Infectious Diseases Service, Hospital del Mar, 08003 Barcelona, Spain.
  • Montero MM; Infectious Pathology and Antimicrobials Research Group (IPAR), Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), 08003 Barcelona, Spain.
  • Domene-Ochoa S; Department of Medicine, Universitat Autònoma de Barcelona (UAB), 08193 Bellaterra, Spain.
  • López-Causapé C; Department of Medicine and Life Sciences (MELIS), Universitat Pompeu Fabra Barcelona, 08002 Barcelona, Spain.
  • Echeverria D; Infectious Diseases Service, Hospital del Mar, 08003 Barcelona, Spain.
  • Sorlí L; Infectious Pathology and Antimicrobials Research Group (IPAR), Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), 08003 Barcelona, Spain.
  • Campillo N; Department of Medicine and Life Sciences (MELIS), Universitat Pompeu Fabra Barcelona, 08002 Barcelona, Spain.
  • Luque S; CIBER of Infectious Diseases (CIBERINFEC CB21/13/00002 and CB21/13/00099), Institute of Health Carlos III, 28029 Madrid, Spain.
  • Padilla E; Infectious Diseases Service, Hospital del Mar, 08003 Barcelona, Spain.
  • Prim N; Infectious Pathology and Antimicrobials Research Group (IPAR), Institut Hospital del Mar d'Investigacions Mèdiques (IMIM), 08003 Barcelona, Spain.
  • Grau S; Department of Medicine, Universitat Autònoma de Barcelona (UAB), 08193 Bellaterra, Spain.
  • Oliver A; Department of Medicine and Life Sciences (MELIS), Universitat Pompeu Fabra Barcelona, 08002 Barcelona, Spain.
  • Horcajada JP; CIBER of Infectious Diseases (CIBERINFEC CB21/13/00002 and CB21/13/00099), Institute of Health Carlos III, 28029 Madrid, Spain.
Antibiotics (Basel) ; 11(11)2022 Oct 22.
Article em En | MEDLINE | ID: mdl-36358110
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Ano de publicação: 2022 Tipo de documento: Article